Shennon Biotechnologies
3 known investors
ShennonBio develops immunotherapy technologies using microfluidic engineering, computational biology, and immunology to advance T cell engineering for cancer treatment. The company serves therapeutic development organizations working on cell and gene therapies.
Founders & leadership
LS
Li Sun, PhDFounder/CEO
Investors · 3
In the news
- Shennon Biotechnologies raises $13 million to find better targets faster against cancer - San Francisco Business Timesbizjournals.com · 2023
- Shennon Biotechnologies Raises $13M in Seed Financingfinsmes.com · 2023
- Shennon Biotechnologies Raises $13M Seed Financing to Accelerate Immunotherapy Target Discovery with Proprietary Single-Cell Functional Screening Platformbusinesswire.com · 2023
- Shennon Biotechnologies - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2023
- Shennon Biotechnologies - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2023
- Shennon Biotechnologies 3/13/2023 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com